STOCK TITAN

Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Corbus Pharmaceuticals (NASDAQ: CRBP) announced that CEO Yuval Cohen, Ph.D., will participate in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on March 17, 2022, at 8:00 AM ET. The event will include virtual one-on-one meetings for registered investors. A live webcast will be available on the company’s website, with a replay accessible two hours post-event for 90 days. Corbus focuses on innovative immunology solutions targeting the immune system and cancer.

Positive
  • None.
Negative
  • None.

NORWOOD, Mass., March 11, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today announcing that  Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on March 17, 2022 at 8:00 AM ET.

In addition to the fireside chat, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference.

A live webcast of the fireside chat will be accessible on the Events page of the Investors section of the Corbus website, www.corbuspharma.com. The webcast replay will be available approximately two hours after the event and will be archived for 90 days.

About Corbus 
Corbus is an immunology company committed to connecting innovation to our purpose of improving lives by developing new medicines that target the nexus between the immune system and cancer. Corbus' current pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. Corbus is headquartered in Norwood, Massachusetts. For more information on Corbus, visit corbuspharma.com. Connect with us on Twitter, LinkedIn and Facebook.

INVESTOR CONTACT:
Brian Walsh, VP, Corporate Development
Email: brian.walsh@corbuspharma.com
Phone: +1 (781) 264 8944

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/corbus-pharmaceuticals-to-present-at-the-oppenheimer-32nd-annual-healthcare-conference-301500516.html

SOURCE Corbus Pharmaceuticals

FAQ

What event will Corbus Pharmaceuticals participate in on March 17, 2022?

Corbus Pharmaceuticals will participate in the Oppenheimer 32nd Annual Healthcare Conference.

What time is the Corbus Pharmaceuticals fireside chat scheduled?

The fireside chat is scheduled for 8:00 AM ET.

Will there be a live webcast of the Corbus Pharmaceuticals event?

Yes, a live webcast of the fireside chat will be available on Corbus' website.

How long will the webcast replay of the Corbus Pharmaceuticals event be available?

The webcast replay will be available for 90 days.

What is the focus of Corbus Pharmaceuticals' research and development?

Corbus Pharmaceuticals focuses on developing new medicines targeting the immune system and cancer.

Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

CRBP Rankings

CRBP Latest News

CRBP Stock Data

160.04M
11.18M
0.75%
105.26%
19.72%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NORWOOD